Top

Published in:

01-07-2005 | Free Paper

New tined lead electrode in sacral neuromodulation: experience from a multicentre European study

Authors: Michele Spinelli, Ernest Weil, Edoardo Ostardo, Giulio Del Popolo, José L. Ruiz-Cerdá, Gustav Kiss, John Heesakkers

Published in: World Journal of Urology | Issue 3/2005

Abstract

The use of a new tined lead electrode for sacral neuromodulation (SNS) was evaluated in a European study including 127 patients with chronic voiding dysfunction. The tined lead can be implanted during the first stage of the SNS procedure, which makes a longer test period possible before implanting the pulse generator in a second stage. Implantation of the tined lead was performed under local anaesthesia in 89% of patients. Screening lasted on average 30 days. Screening with the tined lead was considered successful by the physicians in 77% of patients (n=72). In 74% of first stage patients (n=70), at least 50% improvement in the main symptoms versus baseline was obtained. This was sustained for up to 6 weeks. All of these patients received the pulse generator in a second stage. The outcome of this study supports the use of the tined lead electrode as a screening tool in SNS therapy.

Abrams P, Blaivas JG, Fowler CJ et al. (2003) The role of neuromodulation in the management of urinary urge incontinence. BJU Int 91:355–359PubMed

Bosch R, Groen J (2000) Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol 163:1219–1222CrossRefPubMed

Chai TC, Mamo GJ (2001) Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology 58:786–790CrossRefPubMed

Everaert K, Kerckhaert W, Caluwaerts H et al. (2004) A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol 45:649–654CrossRefPubMed

Everaert K, Plancke H, Lefevere F et al. (1997) The urodynamic evaluation of neuromodulation in patients with voiding dysfunction. Br J Urol 79:702–707PubMed

Janknegt RA, Weil EHJ, Eerdmans PH (1997) Improving neuromodulation technique for refractory voiding dysfunction: two-stage implant. Urology 78:39–46

Jonas U, Fowler CJ, Chancellor MB et al. (2001) Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 165:15–19CrossRefPubMed

Kinchen KS, Burgio K, Diokno AC et al. (2003) Factors associated with women’s decisions to seek treatment for urinary incontinence. J Women’s Health 12:687–698

Miner PB (2004) Economic and personal impact of fecal and urinary incontinence. Gastroenterology 126 [Suppl 1]:S8-S13

10.

Scheepens WA, Weil EH, Van Koeveringe GA et al. (2001) Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation—a multicentre study. Eur Urol 40:434–438CrossRefPubMed

11.

Schmidt RA, Senn E, Tanagho EA (1990) Functional evaluation of sacral nerve root integrity. Report of a technique. Urology 35:388–392CrossRefPubMed

12.

Shaker HS, Hassouna M (1998) Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol 159:1476–1478CrossRefPubMed

13.

Siegel SW (2002) Sacral nerve stimulation: PNE. In: Jonas U, Grünewald V (eds) New perspectives in sacral nerve stimulation. Martin Dunitz, London, pp 99–106

14.

Spinelli M, Giardiello G, Gerber M et al. (2003) New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 170:1905–1907CrossRefPubMed

15.

Tanagho EA, Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140:1331–1339PubMed

16.

Tanago EA, Schmidt RA (1991) In: Krane RJ, Siroky MB (eds) Clinical neurology, 2nd edn. Little Brown, Boston, pp 643–648

17.

Van Kerrebroeck P, Van Voskuilen A, Lycklama A Nyeholt AA, Dijkema H, Bemelmans B, Fall M, Fowler C, Das A, Milam D, Siegel S, Van den Hombergh U, PAS Study Group (2004) Long-term results of Interstim therapy for voiding disorders demonstrate sustained efficacy and acceptable safety profile. Eur Urol [Suppl] 3:170

18.

Van Voskuilen A, Van Kerrebroeck P, Dijkema H, Bemelmans B, Lycklama A Nijholt A, Fall M, Jonas U, Fowler CJ, Das AK, Milam D, Siegel SW, Van den Hombergh U (2004) Lasting improvement is demonstrated in patients with voiding disorders treated with sacral nerve stimulation. J Urol 171 [Suppl 4]: 328

Title: New tined lead electrode in sacral neuromodulation: experience from a multicentre European study
Authors: Michele Spinelli
Ernest Weil
Edoardo Ostardo
Giulio Del Popolo
José L. Ruiz-Cerdá
Gustav Kiss
John Heesakkers
Publication date: 01-07-2005
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 3/2005
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-005-0502-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

New tined lead electrode in sacral neuromodulation: experience from a multicentre European study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2005

A new technique combining both polypropylene and vaginal wall sling procedures: can it minimize the risk of urethral and vaginal erosion occurring with synthetic materials?

Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment?

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie

Combination of surgery and immunotherapy in metastatic renal cell carcinoma

Novel approaches in the therapy of metastatic renal cell carcinoma